3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Bone Cancer in 2 studies
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, G | 1 |
| Pan, X | 1 |
| Liu, X | 2 |
| Zhu, Y | 1 |
| Ma, Y | 1 |
| Du, C | 1 |
| Mao, C | 1 |
| Hiraga, T | 1 |
| Kizaka-Kondoh, S | 1 |
| Hirota, K | 1 |
| Hiraoka, M | 1 |
| Yoneda, T | 1 |
2 other studies available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Bone Cancer
| Article | Year |
|---|---|
HIF-1α-Mediated Mitophagy Determines ZnO Nanoparticle-Induced Human Osteosarcoma Cell Death both In Vitro and In Vivo.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Death; Cell Proliferation; Drug Screening Assays, Antitu | 2020 |
Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
Topics: Animals; Bone Neoplasms; Breast Neoplasms; Caspase 3; Cell Hypoxia; Cell Line, Tumor; Female; Humans | 2007 |